| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adding socioeconomic status to Framingham scoring might also improve stroke risk evaluation in young adults with hypertension
|
Jolobe, Oscar M.P.
|
|
2009
|
158 |
3 |
p. e35-
1 p.
|
artikel
|
| 2 |
Are ejection fraction measurements by echocardiography and left ventriculography equivalent?
|
Joffe, Samuel W.
|
|
2009
|
158 |
3 |
p. 496-502
7 p.
|
artikel
|
| 3 |
Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors
|
De Luca, Giuseppe
|
|
2009
|
158 |
3 |
p. 416-421
6 p.
|
artikel
|
| 4 |
Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials
|
Felker, G. Michael
|
|
2009
|
158 |
3 |
p. 422-430
9 p.
|
artikel
|
| 5 |
B-type natriuretic peptide–guided management and outcome in patients with obesity and dyspnea—Results from the BASEL study
|
Noveanu, Markus
|
|
2009
|
158 |
3 |
p. 488-495
8 p.
|
artikel
|
| 6 |
Contents
|
|
|
2009
|
158 |
3 |
p. A1-A5
nvt p.
|
artikel
|
| 7 |
Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path Initiative
|
Piccini, Jonathan P.
|
|
2009
|
158 |
3 |
p. 317-326
10 p.
|
artikel
|
| 8 |
Current status of cardiac rehabilitation in Latin America and the Caribbean
|
Korenfeld, Yoel
|
|
2009
|
158 |
3 |
p. 480-487
8 p.
|
artikel
|
| 9 |
Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: Observations from the PROTECT-TIMI 30 Trial
|
Wilson, Sean R.
|
|
2009
|
158 |
3 |
p. 386-391
6 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2009
|
158 |
3 |
p. A6-
1 p.
|
artikel
|
| 11 |
Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: A TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)–Thrombolysis in Myocardial Infarction (TIMI) 38 Substudy
|
Pride, Yuri B.
|
|
2009
|
158 |
3 |
p. e21-e26
nvt p.
|
artikel
|
| 12 |
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 trial
|
Morrow, David A.
|
|
2009
|
158 |
3 |
p. 335-341.e3
340666 p.
|
artikel
|
| 13 |
Heart failure disease management program experience in 4,545 heart failure admissions to a community hospital
|
Pazin-Filho, Antonio
|
|
2009
|
158 |
3 |
p. 459-466
8 p.
|
artikel
|
| 14 |
Information for Readers
|
|
|
2009
|
158 |
3 |
p. A7-
1 p.
|
artikel
|
| 15 |
Mechanisms of exercise intolerance in patients with hypertrophic cardiomyopathy
|
Le, Vy-Van
|
|
2009
|
158 |
3 |
p. e27-e34
nvt p.
|
artikel
|
| 16 |
Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort
|
Ip, John
|
|
2009
|
158 |
3 |
p. 364-370.e1
3337 p.
|
artikel
|
| 17 |
Myocardial infarction in saphenous percutaneous intervention: Are we really doing our best?
|
Lozano, Iñigo
|
|
2009
|
158 |
3 |
p. e39-
1 p.
|
artikel
|
| 18 |
Percutaneous coronary intervention in the Occluded Artery Trial: Procedural success, hazard, and outcomes over 5 years
|
Buller, Christopher E.
|
|
2009
|
158 |
3 |
p. 408-415
8 p.
|
artikel
|
| 19 |
Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era
|
de Jong, Jonas S.S.G.
|
|
2009
|
158 |
3 |
p. 467-472
6 p.
|
artikel
|
| 20 |
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction
|
Traverse, Jay H.
|
|
2009
|
158 |
3 |
p. 356-363
8 p.
|
artikel
|
| 21 |
Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): A factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India
|
Chow, Clara K.
|
|
2009
|
158 |
3 |
p. 349-355
7 p.
|
artikel
|
| 22 |
Response to "Adding socioeconomic status to Framingham scoring might also improve stroke risk evaluation in young adults with hypertension"
|
Fiscella, Kevin
|
|
2009
|
158 |
3 |
p. e37-
1 p.
|
artikel
|
| 23 |
Response to "Myocardial infarction in saphenous percutaneous intervention: Are we really doing our best?"
|
Bonello, Laurent
|
|
2009
|
158 |
3 |
p. e41-
1 p.
|
artikel
|
| 24 |
Risk factors and comorbidities associated with obesity in children and adolescents after the arterial switch operation and Ross procedure
|
Pasquali, Sara K.
|
|
2009
|
158 |
3 |
p. 473-479
7 p.
|
artikel
|
| 25 |
ST-elevation myocardial infarction patients can be enrolled in randomized trials before emergent coronary intervention without sacrificing door-to-balloon time
|
Blankenship, James C.
|
|
2009
|
158 |
3 |
p. 400-407
8 p.
|
artikel
|
| 26 |
Systematic review of studies of the effect of hyperoxia on coronary blood flow
|
Farquhar, Hamish
|
|
2009
|
158 |
3 |
p. 371-377
7 p.
|
artikel
|
| 27 |
The Cholesterol, Hypertension, and Glucose Education (CHANGE) study for African Americans with diabetes: Study design and methodology
|
Powers, Benjamin J.
|
|
2009
|
158 |
3 |
p. 342-348
7 p.
|
artikel
|
| 28 |
The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction
|
Gheorghiade, Mihai
|
|
2009
|
158 |
3 |
p. 437-443
7 p.
|
artikel
|
| 29 |
The prognostic importance of modifiable risk factors after heart transplantation
|
Arora, Satish
|
|
2009
|
158 |
3 |
p. 431-436
6 p.
|
artikel
|
| 30 |
The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA•CER) trial: study design and rationale
|
The TRA•CER Executive and Steering Committees,
|
|
2009
|
158 |
3 |
p. 327-334.e4
3.339674E6 p.
|
artikel
|
| 31 |
Two-dimensional strain analysis in patients with hypertrophic cardiomyopathy and normal systolic function: A 12-month follow-up study
|
Paraskevaidis, Ioannis A.
|
|
2009
|
158 |
3 |
p. 444-450
7 p.
|
artikel
|
| 32 |
Use of β-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: Are we on target?
|
Herman, Michael
|
|
2009
|
158 |
3 |
p. 378-385
8 p.
|
artikel
|
| 33 |
Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada
|
Elbarouni, Basem
|
|
2009
|
158 |
3 |
p. 392-399
8 p.
|
artikel
|
| 34 |
Weekend hospital admission and discharge for heart failure: Association with quality of care and clinical outcomes
|
Horwich, Tamara B.
|
|
2009
|
158 |
3 |
p. 451-458
8 p.
|
artikel
|
Tijdschrift beschrijving